FDA approves J&J to make bulk Doxil at closed Ben Venue plant

Janssen has another manufacturer finish off the drug as part of an 'alternative' process

March 25, 2014 | By Eric Palmer

Read more: FDA approves J&J to make bulk Doxil at closed Ben Venue plant - FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/story/fda-approves-jj-make-bulk-doxil-closed-ben-venue-plant/2014-03-25#ixzz2x09NMNZN
Subscribe at FiercePharma Manufacturing